CJC-1295
Reducing body fat
Improving sleep quality
Accelerating recovery from injuries
Supporting anti-aging therapies
CJC-1295 muscle growth & repair
Mechanism of action
CJC-1295 binds to GHRH receptors in the pituitary gland, promoting the release of GH. The addition of a Drug Affinity Complex (DAC) extends its half-life by allowing it to bind to albumin, resulting in prolonged GH secretion over several days.
Notable Studies
A study published in the Journal of Clinical Endocrinology & Metabolism demonstrated that subcutaneous administration of CJC-1295 led to sustained increases in GH and IGF-1 levels in healthy adults
Risk Associated
Injection site reactions (redness, swelling)
Flushing
Headaches
Nausea
Potential overstimulation of GH production, leading to conditions like acromegaly
Dosage
CJC-1295 with DAC: Typically administered at 1-2 mg once or twice weekly.
CJC-1295 without DAC: Commonly dosed at 100-200 mcg daily, often in combination with other peptides like Ipamorelin.
External link
CJC-1295
Reducing body fat
Improving sleep quality
Accelerating recovery from injuries
Supporting anti-aging therapies
Mechanism of action
CJC-1295 binds to GHRH receptors in the pituitary gland, promoting the release of GH. The addition of a Drug Affinity Complex (DAC) extends its half-life by allowing it to bind to albumin, resulting in prolonged GH secretion over several days.
Risk
Associated
Injection site reactions (redness, swelling)
Flushing
Headaches
Nausea
Potential overstimulation of GH production, leading to conditions like acromegaly
Notable Studies
A study published in the Journal of Clinical Endocrinology & Metabolism demonstrated that subcutaneous administration of CJC-1295 led to sustained increases in GH and IGF-1 levels in healthy adults
Dosage
CJC-1295 with DAC: Typically administered at 1-2 mg once or twice weekly.
CJC-1295 without DAC: Commonly dosed at 100-200 mcg daily, often in combination with other peptides like Ipamorelin.
External link
CJC-1295
Reducing body fat
Improving sleep quality
Accelerating recovery from injuries
Supporting anti-aging therapies
Mechanism of action
CJC-1295 binds to GHRH receptors in the pituitary gland, promoting the release of GH. The addition of a Drug Affinity Complex (DAC) extends its half-life by allowing it to bind to albumin, resulting in prolonged GH secretion over several days.
Risk
Associated
Injection site reactions (redness, swelling)
Flushing
Headaches
Nausea
Potential overstimulation of GH production, leading to conditions like acromegaly
Notable Studies
A study published in the Journal of Clinical Endocrinology & Metabolism demonstrated that subcutaneous administration of CJC-1295 led to sustained increases in GH and IGF-1 levels in healthy adults
Dosage
CJC-1295 with DAC: Typically administered at 1-2 mg once or twice weekly.
CJC-1295 without DAC: Commonly dosed at 100-200 mcg daily, often in combination with other peptides like Ipamorelin.
External link
-
Teichman SL, Neale A, Lawrence B, et al. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. J Clin Endocrinol Metab. 2006;91(3):799-805.
-
CJC-1295. Wikipedia. https://en.wikipedia.org/wiki/CJC-1295
-
CJC-1295 Explained: What It Is, How It Works and What You Need to Know. Unfiltered Online. https://unfilteredonline.com/cjc-1295-explained-what-it-is-how-it-works-and-what-you-need-to-know/
-
Risks of Unapproved Peptides for Health & Performance Enhancement. Ortho and Wellness. https://www.orthoandwellness.com/blog/unveiling-the-hidden-dangers-the-risks-of-using-unapproved-peptides-for-health-and-performance-enhancement
-
Ipamorelin CJC 1295: Ideal Dosage for Fitness. Anti-Aging Northwest. https://antiagingnorthwest.com/ipamorelin-cjc-1295-ideal-dosage-for-fitness/